sanjay gupta glp 1 Why GLP-1s May or May Not Be for You - Chasing Life with Dr. Dr. Sanjay Gupta - Healthcare

lowest tolerated dose Phase Step 2 Weeks Weeks 5-8 Cagrilintide Dose 0.5 mg/week Purpose Dose escalation Phase Step 3 Weeks Weeks 9-12 Cagrilintide Dose 1.0 mg/week Purpose GI side effects often peak here Phase Step 4 Weeks Weeks 13-16 Cagrilintide Dose 1.7 mg/week Purpose Approaching maintenance Phase Maintenance Weeks Weeks 17+ Cagrilintide Dose 2.4 mg/week Purpose Target dose used in late-stage study protocols Each step lasts 4 weeks

doi: 10.1074/jbc.M111.279208

Overview of the possible role of vitamin C in management of COVID-19

These timeframes align with the protocols used in published peptide efficacy studies

Frequently Asked Questions What is the difference between Mounjaro and traditional GLP-1 receptor agonists